Yoder Wealth Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$242K Buy
960
+18
+2% +$3.87K 0.09% 117
2026
Q1
$205K Sell
942
-10
-1% -$2.22K 0.09% 121
2025
Q4
$218K Buy
952
+48
+5% +$10.9K 0.1% 111
2025
Q3
$209K Buy
+904
New +$184K 0.1% 112

Other funds holding ABBV

Yoder Wealth Management's ABBV Position: Q2 2026 in Review

Yoder Wealth Management increased its AbbVie (ABBV) stake by 1.9% in Q2 2026, buying an estimated $3.87K and bringing the position to 960 shares worth $242K. The position accounts for 0.09% of the portfolio, ranked #117.

Yoder Wealth Management first reported a position in ABBV in Q3 2025 and has held it in 4 quarters since. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Yoder Wealth Management held 960 shares of AbbVie worth $242K as of Q2 2026.
  • Yoder Wealth Management bought 18 AbbVie shares in Q2 2026, an estimated $3.87K.
  • AbbVie made up 0.09% of Yoder Wealth Management's portfolio in Q2 2026, its #117 holding.
  • Yoder Wealth Management first reported a position in AbbVie in Q3 2025 and has held it in 4 quarters since.
  • 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Yoder Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.